Exploring the Mechanism of Inhibition of Au Nanoparticles on the Aggregation of Amyloid-β(16-22) Peptides at the Atom Level by All-Atom Molecular Dynamics
Open Access
- 20 June 2018
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (6) , 1815
Abstract
The abnormal self-assembly of the amyloid-β peptide into toxic β-rich aggregates can cause Alzheimer’s disease. Recently, it has been shown that small gold nanoparticles (AuNPs) inhibit Aβ aggregation and fibrillation by slowing down the nucleation process in experimental studies. However, the effects of AuNPs on Aβ oligomeric structures are still unclear. In this study, we investigate the conformation of Aβ(16-22) tetramers/octamers in the absence and presence of AuNPs using extensive all-atom molecular-dynamics simulations in explicit solvent. Our studies demonstrate that the addition of AuNPs into Aβ(16-22) solution prevents β-sheet formation, and the inhibition depends on the concentration of Aβ(16-22) peptides. A detailed analysis of the Aβ(16-22)/Aβ(16-22)/water/AuNPs interactions reveals that AuNPs inhibit the β-sheet formation resulting from the same physical forces: hydrophobic interactions. Overall, our computational study provides evidence that AuNPs are likely to inhibit Aβ(16-22) and full-length Aβ fibrillation. Thus, this work provides theoretical insights into the development of inorganic nanoparticles as drug candidates for treatment of AD.Keywords
Funding Information
- Innovation Program of Shanghai Municipal Education Commission (13ZZ129)
- National Natural Science Foundation of China (11374204, 51672172)
This publication has 49 references indexed in Scilit:
- The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation studyPhysical Chemistry Chemical Physics, 2016
- Aβ(1–42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's diseaseNature Structural & Molecular Biology, 2015
- The molecular mechanism of fullerene-inhibited aggregation of Alzheimer's β-amyloid peptide fragmentNanoscale, 2014
- Protein Misfolding, Functional Amyloid, and Human DiseaseAnnual Review of Biochemistry, 2006
- Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolutionJournal of Molecular Medicine, 2003
- Amyloid Fibril Formation by Aβ16-22, a Seven-Residue Fragment of the Alzheimer's β-Amyloid Peptide, and Structural Characterization by Solid State NMRBiochemistry, 2000
- Amyloid β-Protein FibrillogenesisJournal of Biological Chemistry, 1999
- Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopyNature Medicine, 1998
- Kinetic theory of fibrillogenesis of amyloid β-proteinProceedings of the National Academy of Sciences, 1997
- Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease βA4 peptidesJournal of Molecular Biology, 1992